Background Bronchoconstriction has developed after inhalation oflipopolysaccharide in a dose of 20 pg in asthmatic patients and of 200 pg in normal subjects.
This study set out to determine whether the bronchial response to lipopolysaccharide was related to non-specific bronchial responsiveness and atopy. Methods Sixteen subjects with a fall in specific airway conductance of 40% (PD. Results FEV, fell significantly more after lipopolysaccharide than after diluent inhalation, the difference in mean (SE) FEVy being 4-6% ( 
Results
The mean difference in change in FEV1 from baseline between solvent and lipopolysaccharide was 4-6% (5-4%) in the 16 patients. The difference was significant at 60 minutes (p < 0 001) and lasted more than five hours (fig 1) . There was a significant inverse relation between the response to lipopolysaccharide and the response to histamine (r = -0-61 and -0-73 for LPS 15-300 v log PD20FEV, (p < 0-02) and log PD40sGaw (p < 0 001); r = -0-64 and -0-74 for area LPS 15-300 v log PD20FEV1 (p < 0-01) and log PD40sGaw (p < 0o001)).
The group who responded to lipopolysaccharide (n = 8) had a mean fall in FEV1 (LPS 15-300) of 8-6% (3-1%) and a maximal fall at 60 minutes of 12-9% (6-8%) (fig 2) . Responders and non-responders did not differ significantly in terms of age, sex ratio, baseline FEV1 or proportions of smokers and of atopic individuals (table 2) 
Discussion
Because of the wide variation in structure and biological activity of endotoxin we studied lipopolysaccharide from E coli as this has shown lung toxicity in vitro and after inhalation in animals'36 [16] [17] [18] and man.'0 19
There was a wide range of response to lipopolysaccharide amongst the 16 subjects, so the group was divided into lipopolysaccharide responders and non-responders. The main characteristic of the subjects who produced a significant fall in FEV, after inhaling 20 pg lipopolysaccharide was their greater histamine bronchial responsiveness. This is consistent with studies of van The fall in FEV, induced by lipopolysaccharide was seen at 30 minutes, peaked at 60 minutes, and lasted more than five hours; this is consistent with the effect of inhaled lipopolysaccharide in patients with chronic bronchitis'9 or chronic non-specific lung disease with bronchial hyperreactivity.20 The time course of the bronchial response to lipopolysaccharide is also consistent with cell recruitment into the airways after inhalation of endotoxin in animal models. In guinea pigs inhalation of endotoxin caused an influx of neutrophils in the airways at intervals ranging from 90 minutes3 2122 to four hours'8 and lasting at least 24 hours.31822
The fall in FEV, at 15 minutes was not significant. Absence of the early bronchoconstriction, seen in IgE mediated reactions, suggests that the response to lipopolysaccharide could be mediated by a non-IgE mechanism. This is supported by the presence of a bronchial response to lipopolysaccharide in some non-atopic subjects in the present study, by the absence of an immediate prick skin test response to lipopolysaccharide in atopic subjects,23 and by the absence of lipopolysaccharide induced histamine release by basophils from atopic subjects.24
Studies in monozygotic and dizygotic twins25 suggest that factors determining bronchial responsiveness are mainly exogenous rather than genetic. These may be IgE specific (sensitisation limited to the atopic subjects) or nonspecific (in both atopic and non-atopic subjects). In our study the response to lipopolysaccharide correlated with nonspecific bronchial responsiveness but was independent of the presence or absence of atopy. Lipopolysaccharide could be a factor of clinical relevance in both atopic and non-atopic bronchial diseases like intrinsic and extrinsic asthma, chronic bronchitis, and some occupational lung diseases.
